Intellipharmaceutics International Inc. — Form D
Intellipharmaceutics International Inc. of TORONTO, A6, a company, filed a Form D exempt-offering notice with the SEC on 2011-02-15. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-02-15
- Form: D
- Accession: 0001458511-11-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $12.0M
- Amount sold: $12.0M
- Investors: 28
- Date of first sale: 2011-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-155332
Issuer
- Name: Intellipharmaceutics International Inc.
- CIK: 0001474835
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2009
- Address: 30 WORCESTER ROAD, TORONTO, A6, M9W 5X2
- Phone: 416-798-3001
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| John N Allport | Director | Toronto, A6 |
| John N Allport | Executive Officer | Toronto, A6 |
| Shameze N Rampertab | Executive Officer | Toronto, A6 |
| Patrick N Yat | Executive Officer | Toronto, A6 |
| Eldon R Smith | Director | Oakville, A6 |
| Eldon Smith | Director | Toronto, A6 |
| Kenneth Keirstead | Director | Toronto, A6 |
| Andrew Patient | Executive Officer | Toronto, A6 |
| Bahadur Madhani | Director | Toronto, A6 |
| Amina Odidi | Director | Toronto, A6 |
| Amina Odidi | Executive Officer | Toronto, A6 |
| Isa Odidi | Director | Toronto, A6 |
| Isa Odidi | Executive Officer | Toronto, A6 |
| Kenneth R Keirstead | Director | Toronto, A6 |
| Bahadur R Madhani | Director | Toronto, A6 |
| Michael R Campbell | Executive Officer | Toronto, A6 |
| Andrew R Patient | Executive Officer | Toronto, A6 |
Other filings by this issuer (3)
More